Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
about
Differential response of flat and polypoid colitis-associated colorectal neoplasias to chemopreventive agents and heterocyclic aminesDrug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions.The position of the amino group on the benzene ring is critical for mesalamine's improvement of replication fidelity.Increased DNA strand breaks in mononuclear cells from patients with rheumatoid arthritis.Hydrogen peroxide stimulates rat colonic prostaglandin production and alters electrolyte transportOral 4-aminosalicylic acid versus 5-aminosalicylic acid slow release tablets. Double blind, controlled pilot study in the maintenance treatment of Crohn's ileocolitis.Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease.Inhibition of red cell membrane lipid peroxidation by sulphasalazine and 5-aminosalicylic acid.Drug therapy of ulcerative colitisDiminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase contentOlsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind studyMedical therapy in Crohn's disease.5-aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phosphate dehydrogenase in colon epithelial cellsPhagocytes, toxic oxygen metabolites and inflammatory bowel disease: implications for treatment.Colon-specific prodrugs of 4-aminosalicylic acid for inflammatory bowel disease.Current concepts in the pathogenesis of Crohn's disease.Aminosalicylates.Topical therapy.Male contraception: current status and future prospects.Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers.Effect of sulphasalazine and sulphapyridine on neutrophil superoxide production: role of cytosolic free calcium.Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis.Mechanism of action of 5-arninosalicylic acid.Inhibition of cell mediated cytotoxicity by sulphasalazine: effect of in vivo treatment with 5-aminosalicylic acid and sulphasalazine on in vitro natural killer cell activityEffect of sulphasalazine and its active metabolite, 5-amino-salicylic acid, on toxic oxygen metabolite production by neutrophils.Scavenging of reactive oxygen and nitrogen species by the prodrug sulfasalazine and its metabolites 5-aminosalicylic acid and sulfapyridine.Molecular basis of the potential of mesalazine to prevent colorectal cancer.Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.Scavenger effect of sulphasalazine (SASP), 5-aminosalicylic acid (5-ASA), and olsalazine (OAZ)NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.Identification of PMN-released Mutagenic Factors in a Co-culture Model for Colitis-associated Cancer.Sulphasalazine fails to prevent development of mucosal ulceration and 5-lipoxygenase activity in guinea-pigs with chronic inflammatory bowel disease induced by combined bacterial immunization and oral carrageenin.5-aminosalicylic acid (5-ASA) can reduce levels of oxidative DNA damage in cells of colonic mucosa with and without fecal stream.
P2860
Q26864562-A88FC5D5-A9E5-4E27-8D2C-FBC6CE6E3BDBQ33396340-23D514AA-D8B6-4D64-992F-79CB0863D65CQ33509847-1C3AC800-612E-4FB8-8965-7475D61C73D5Q33564170-764A02EB-E083-484E-B7C4-A210A36B1093Q34255043-BA6193C2-1DBA-4203-92E8-F5FA84088D98Q34379983-A0AE7AAA-1287-4424-A9F8-6D7DB85B2EB7Q34395602-4EA808B3-0B52-4D8C-9B99-FAFC8C94F6EDQ34395621-E62CCFF6-1B32-45C5-90F5-4B70302DE718Q34403155-59F4E3D1-953F-48A0-9C32-501C21B1B85BQ34528907-D5907026-C6A3-4C21-8C20-3F9832279E35Q34532266-6FD8EF1C-85B6-4370-B8BC-5C87A33CBCA8Q35272521-3323C37E-54AF-4395-A39E-1D7D887F0A2DQ35354113-C64F23ED-7B26-471D-A843-32299D0BCB25Q36816563-9FB97D9A-CF01-4D61-A96F-9FA8EF29463EQ37682512-2CBB56AB-3ACC-4253-8089-5F7E8D61BD4BQ37804831-A4EC9FD0-AAEF-4455-B25C-536EB82FFC3BQ38008871-544D3756-E3EC-4DF8-897A-AA888B4D8CB8Q38072231-C1EA9E94-33F2-4BE6-8E84-07F7D65AFF59Q39577556-0F3B51EA-C425-4E64-97E4-AB64F124692BQ40345193-52C9A933-4B18-4B86-9DD0-B6D31D1396FFQ41222035-1E55472F-6C29-4113-8057-03F8A7AE94EEQ41862338-0C2A7392-4D31-4E52-B2B4-AADDC7601682Q42106723-E5E0F18A-42BA-4752-B886-4AD1E625F8B4Q42215266-CE02BC6E-575E-4617-A3A7-9B28D5324D20Q42275097-5DF2A576-5202-40FB-947E-E7AD810DD5C4Q42761449-3C86D5C8-2BB6-4218-8BBB-AE81442020A6Q43064986-C62050AF-253B-4692-BC97-D5279D5AAC52Q43203843-7FA3992F-CC04-4659-A706-6698B9FC7FD2Q43219287-34718E65-CBA3-4CC2-A32E-54A3FABFAE47Q44559483-DAE46292-81D3-4E06-965C-7D5604703A92Q46268203-B5E71A07-C1FC-4EDD-A4A0-235F88708650Q46517658-D55E72E0-A1C0-49D0-B1D5-E13EA82086DCQ53291853-9204F85F-7B1E-413D-B6D8-AF0F0F0BDFA5
P2860
Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Effect of sulphasalazine and i ...... on of reactive oxygen species.
@en
type
label
Effect of sulphasalazine and i ...... on of reactive oxygen species.
@en
prefLabel
Effect of sulphasalazine and i ...... on of reactive oxygen species.
@en
P2093
P2860
P356
P1433
P1476
Effect of sulphasalazine and i ...... on of reactive oxygen species.
@en
P2093
P2860
P304
P356
10.1136/GUT.28.2.190
P407
P577
1987-02-01T00:00:00Z